Side-by-side comparison of AI visibility scores, market position, and capabilities
Artillery is a modern open-source load testing and smoke testing tool built for cloud-native architectures, supporting HTTP, WebSockets, and custom protocols.
Artillery is a modern open-source load testing and smoke testing framework designed for cloud-native application architectures, offering a YAML-first test definition syntax that makes performance tests readable and maintainable alongside application code. Artillery was built with the philosophy that load testing configuration should be version-controlled, code-reviewed, and treated as a first-class artifact of the software development process rather than a one-off script someone runs before a big launch. Its YAML scenario definitions express traffic patterns, virtual user flows, request sequences, and ramp-up profiles in a format that is readable by engineers who did not write the test, making load test maintenance a team responsibility rather than tribal knowledge held by a single performance specialist.
SF AI coding platform with Replit Agent building full-stack apps from natural language for 35M+ users; $97.4M a16z-backed at $1.16B valuation competing with Cursor and GitHub Copilot for AI-native development.
Replit is a San Francisco-based AI-powered coding platform — backed with $97.4 million raised at a $1.16 billion valuation from a16z, Y Combinator, and others — providing browser-based development environments, collaborative coding, and AI code generation through Replit Agent (an autonomous AI that builds full-stack applications from natural language prompts) for 35 million+ developers, students, and non-technical founders globally. Founded in 2016 by Amjad Masad and Haya Masad, Replit has evolved from a collaborative online IDE to a comprehensive AI-native development platform where non-programmers can describe an application and have it built, deployed, and hosted without writing code.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.